Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-01

FDA Approved: BUTORPHANOL TARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approves a generic version of butorphanol tartrate under an original application for Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butorphanol Tartrate (Butorphanol tartrate)

Snippet

ORIG AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)